Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TELA Bio, Inc.TELA · Entity 7381 | Chief Commercial Officer | March 31, 2024 | April 02, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TELA Bio, Inc.
Report date March 31, 2024 · Filed April 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,129 |
Reported balance
After 2024-03-31 transaction · row 1
1 source rowRow 1 · 2024-03-31 · Tax withholding · Disposed 163 · Balance 48,129 F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2024 Filed Apr 2, 2024 19:42 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 163 | $5.67 | $924.21 |
DisclosureSEC source: 0001062993-24-007839 · form4.xml · nonDerivative · entry 1 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,129 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 24, 2024 Filed Feb 27, 2024 16:35 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 940 | $7.07 | $6,645.80 |
DisclosureSEC source: 0001062993-24-004574 · form4.xml · nonDerivative · entry 3 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,292 F3 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 16:35 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 19,300 | $0.00 Strike: $7.07 | $0.00 |
DisclosureSEC source: 0001062993-24-004574 · form4.xml · derivative · entry 4 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,300 Underlying: Common Stock · 19,300 shares Expires 2034-02-23 F4 · derivative.exercise_date: The option vests 25% on February 23, 2025, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 16:35 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 2,315 | $7.07 | $16,367.05 |
DisclosureSEC source: 0001062993-24-004574 · form4.xml · nonDerivative · entry 2 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,232 F3 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 16:35 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 13,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004574 · form4.xml · nonDerivative · entry 1 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,547 F1 · shares: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2025, subject to the Reporting Person's continuous service through the applicable vesting dates. F2 · balance_after: Includes 156 shares acquired under the Company's employee stock purchase plan on July 31, 2023 and 204 shares acquired under the Company's employee stock purchase plan on January 31, 2024. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 18:02 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 163 | $10.64 | $1,734.32 |
DisclosureSEC source: 0001062993-23-008666 · form4.xml · nonDerivative · entry 1 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,987 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 24, 2023 Filed Feb 27, 2023 19:19 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 940 | $11.03 | $10,368.20 |
DisclosureSEC source: 0001062993-23-005027 · form4.xml · nonDerivative · entry 3 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,150 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 19:19 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $10.50 | $0.00 |
DisclosureSEC source: 0001062993-23-005027 · form4.xml · derivative · entry 4 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,400 Underlying: Common Stock · 26,400 shares Expires 2033-02-23 F3 · derivative.exercise_date: The option vests 25% on February 23, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 19:19 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 906 | $10.50 | $9,513.00 |
DisclosureSEC source: 0001062993-23-005027 · form4.xml · nonDerivative · entry 2 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,090 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 19:19 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 16,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005027 · form4.xml · nonDerivative · entry 1 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,996 F1 · shares: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 16:44 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 163 | $11.63 | $1,895.69 |
DisclosureSEC source: 0001062993-22-009228 · form4.xml · nonDerivative · entry 1 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,196 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 16:24 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 939 | $11.98 | $11,249.22 |
DisclosureSEC source: 0001062993-22-005912 · form4.xml · nonDerivative · entry 1 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,359 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 17:08 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 18,600 | $0.00 Strike: $11.75 | $0.00 |
DisclosureSEC source: 0001062993-22-005775 · form4.xml · derivative · entry 2 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,600 Underlying: Common Stock · 18,600 shares Expires 2032-02-23 F2 · derivative.exercise_date: The option vests 25% on February 23, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 17:08 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 10,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005775 · form4.xml · nonDerivative · entry 1 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,298 F1 · shares: These restricted stock units will vest in four equal annual installments beginning on February 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 14:42 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 2,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000298 · edgar.xml · nonDerivative · entry 1 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,498 F1 · shares: These restricted stock units will vest in four equal annual installments beginning on March 31, 2022, subject to the Reporting Person's continuous service with the Issuer. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 17:24 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (right to buy) · Derivative | 20,400 | $0.00 Strike: $16.99 | $0.00 |
DisclosureSEC source: 0001192482-21-000188 · edgar.xml · derivative · entry 2 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,400 Underlying: Common Stock · 20,400 shares Expires 2031-02-24 F2 · derivative.exercise_date: The option vests 25% on February 24, 2022, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 17:24 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 11,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000188 · edgar.xml · nonDerivative · entry 1 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 F1 · shares: These restricted stock units will vest in four equal annual installments beginning on February 24, 2022, subject to the Reporting Person's continuous service with the Issuer. Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 19:14 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $15.50 | $0.00 |
DisclosureSEC source: 0001192482-20-000068 · edgar.xml · derivative · entry 1 Murphy Peter C. · CIK 0001801542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2030-01-27 F1 · derivative.exercise_date: The option vests 25% on January 27, 2021, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.